Hyundai Bioscience Co. Ltd Cash Flow Quality Index
Hyundai Bioscience Co. Ltd cash flow quality index. Hyundai Bioscience Co. Ltd (048410) has a Cash Flow Quality Index of 5.09x as of June 2024. Operating cash flow of ₩8.02 Billion exceeds net income of ₩1.58 Billion, indicating high earnings quality where cash backs reported profits. See 048410 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Hyundai Bioscience Co. Ltd (2008–2019)
Cash flow quality index of Hyundai Bioscience Co. Ltd from 2008 to 2019. Historical Cash Flow Quality Index for Hyundai Bioscience Co. Ltd across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 048410 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Hyundai Bioscience Co. Ltd Cash Flow Quality Index by Year (2008–2019)
Hyundai Bioscience Co. Ltd cash flow quality index by year from 2008 to 2019. Year-by-year earnings quality comparison for Hyundai Bioscience Co. Ltd. For the full cash flow conversion analysis, see 048410 cash generation efficiency.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 11.96x | ₩9.18 Billion | ₩767.22 Million | ▲ +525.8% |
| 2018 | 1.91x | ₩5.01 Billion | ₩2.62 Billion | ▲ +163.0% |
| 2017 | -3.03x | ₩-3.70 Billion | ₩1.22 Billion | ▼ -2570.3% |
| 2015 | 0.12x | ₩87.36 Million | ₩711.29 Million | ▼ -93.8% |
| 2008 | 1.97x | ₩10.37 Billion | ₩5.26 Billion | — |